ClinicalTrials.govpublic full text
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, chronic myelomonocytic leukemia, myelofibrosis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907907
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.